Michael Trzoss - Concepedia

Concepedia

Author

Michael Trzoss

Amplyx Pharmaceuticals (United States)

Also Known As

MIchael Trzoss, Michael Trzoss, Trzoss, Michael

35

Publications

1.2K

Citations

17

H-Index

29

Concepts

All Affiliations

Amplyx Pharmaceuticals (United States)Arcturus Therapeutics (United States)University of Zurich University of Auckland Lawrence Livermore National Laboratory

MT

About

Michael Trzoss is an author at Amplyx Pharmaceuticals (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	438
2	Natural Sciences	4	4	290
3	Biochemistry	3	3	227
4	Engineering	1	1	29
5	Biomolecular Engineering	1	1	29

Michael Trzoss

×

19

Publications

1.2K

Citations

17

H-Index

	Year	Citations
Singlet Oxygen Production by Peptide-Coated Quantum Dot−Photosensitizer Conjugates James M. Tsay, Michael Trzoss, Lixin Shi, Journal of the American Chemical Society	2007	288
Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents Praveen R. Juvvadi, David Fox, Benjamin G. Bobay, Nature Communications	2019	120
Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE). Part I: Structure guided discovery and optimization of dual targeting agents with potent, broad-spectrum enzymatic activity Leslie W. Tari, Michael Trzoss, Daniel C. Bensen, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryDrug TargetDna Gyrase BBiochemistryNatural Sciences	2012	115
<i>In Vitro</i> and <i>In Vivo</i> Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus Karen Joy Shaw, Wiley A. Schell, Jonathan A. Covel, Antimicrobial Agents and Chemotherapy	2018	113
Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial Agents Leslie W. Tari, Xiaoming Li, Michael Trzoss, PLoS ONE Topoisomerase ComplexesImportant PathogensMolecular BiologyAntimicrobial ChemotherapyChemical Biology	2013	103
Structure-Based Design of New Dihydrofolate Reductase Antibacterial Agents: 7-(Benzimidazol-1-yl)-2,4-diaminoquinazolines Thanh Lam, M.T. Hilgers, Mark L. Cunningham, Journal of Medicinal Chemistry Molecular PharmacologyAntimicrobial Drug DiscoveryBiochemistryAntibioticsMedicine	2014	71
Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines Xiaoming Li, M.T. Hilgers, Mark L. Cunningham, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineStructure-based DesignAntibacterial AgentAntimicrobial Compound	2011	59
APX001 and Other Gwt1 Inhibitor Prodrugs Are Effective in Experimental <i>Coccidioides immitis</i> Pneumonia Suganya Viriyakosol, Mili Kapoor, Sharon Okamoto, Antimicrobial Agents and Chemotherapy	2018	51
Investigations into the cellular actions of the shellfish toxin gymnodimine and analogues Michael Dragunow, Michael Trzoss, Margaret A. Brimble, Environmental Toxicology and Pharmacology Molecular PharmacologyMolecular PhysiologyToxinologyBiochemistryMedicine	2005	41
Preparation of a `Si-centered' chiral auxiliary by resolution Michael Trzoss, Jie Shao, Stefan Bienz Tetrahedron Asymmetry SiliceneChiral AuxiliaryChemistryAsymmetric CatalysisEnantioselective Synthesis	2004	39

Page 1